Search Results - "Oram, D.H."

Long-Term Follow-up of Gonadotrophin-Releasing Hormone Analog Treatment for Recurrent Endometrial Cancer by Jeyarajah, A.R., Gallagher, C.J., Blake, P.R., Oram, D.H., Dowsett, M., Fisher, C., Oliver, R.T.D.

“…To test the antitumor effect of gonadotrophin-releasing hormone (GnRH) analogs, 32 consecutive patients with recurrent endometrial cancer that had progressed…”
Get full text

Immunocytochemical and serological expression of CA 125: a clinicopathological study of 40 malignant ovarian epithelial tumours by Leake, J, Woolas, R P, Daniel, J, Oram, D H, Brown, C L

“…Elevated serum levels of the tumour-associated antigen CA 125 occur in more than 80% of cases of ovarian carcinoma. The antigen can be demonstrated in…”
Get more information

Serum CA 125 in a pregnancy generated by ovum donation by Norman-Taylor, J Q, Woolas, R P, Oram, D H, Grudzinskas, J G

“…Serum CA 125 was measured by radioimmunoassay during the first trimester at intervals of 2 weeks in a woman with Turner's syndrome, who conceived following…”
Get more information

Serum levels of CA 125 during the first trimester of normal outcome, ectopic and anembryonic pregnancies by Jacobs, I J, Fay, T N, Yovich, J, Stabile, I, Frost, C, Turner, J, Oram, D H, Grudzinskas, J G

“…Single serum samples were obtained during the first trimester of pregnancies with a retrospectively normal outcome (n = 150), ectopic pregnancies (n = 38) and…”
Get more information

Diagnosis and management of endometrial hyperplasia by Oram, D.H., Jeyarajah, A.R.

“…Abnormal proliferations of the endometrium form a morphological continuum ranging from simple glandular hyperplasia to frankly invasive cancer. The extremes of…”
Get full text

Obstetrics and gynaecology at the London Hospital by Beedham, T, Grudzinskas, J G, Oram, D H, Hartgill, J C

Get more information